Hydralazine tablets

Hydralazine tablets

Form: Tablets

Strength: 10 mg, 25 mg, 50 mg, 100 mg

Reference Brands: Apresoline(US & Eu)

Category: Hypertension

Hydralazine tablets, marketed as Apresoline, are approved in the US by the FDA and in the EU via EMA for managing severe hypertension and heart failure. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Adequate regional adherence supports timely approval, safe medication use, and worldwide availability, helping healthcare providers manage cardiovascular risks effectively across regions.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Antithymocyte Globulin (ATG) powder for injection

Strength: 250mg/5ml

Form: Lyophilized powder

Reference Brands: Thymoglobulin(US & EU)

View Details Get Enquiry
Methyldopa tablets

Strength: 250 mg, 500 mg, and 750 mg

Form: Tablets

Reference Brands: Aldomet(US)

View Details Get Enquiry
Clonidine Patch

Strength: 0.1 mg/24 hours, 0.2 mg/24 hours, 0.3 mg/24 hours

Form: transdermal patch

Reference Brands: Catapres(US)

View Details Get Enquiry
Clonidine tablets

Strength: 0.1 mg, 0.2 mg, 0.3 mg

Form: Tablets

Reference Brands: Catapres(US)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.